Airways-on-chip models to advance pathology treatment of respiratory organs

Key Points

• Airways-on-chip models offer substantial insights into treatment pathways for respiratory organs, enhancing understanding of pathology.
• Key evidence highlights the potential of these models to improve respiratory health outcomes, especially in chronic conditions.
• Analysis includes biomarker evaluation and treatment response in detailed respiratory organ cultures.
• Findings suggest that airways-on-chip technology could revolutionize respiratory treatments, but more research is needed for clinical application.